What is Palvella Therapeutics, Inc. Common Stock's Market Cap?

Palvella Therapeutics, Inc. Common Stock's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.

What is Palvella Therapeutics, Inc. Common Stock's Enterprise Value?

Palvella Therapeutics, Inc. Common Stock's Enterprise Value is $1.9B, based on as-reported figures from SEC (XBRL) filings.

What is Palvella Therapeutics, Inc. Common Stock's Net Income (TTM)?

Palvella Therapeutics, Inc. Common Stock's Net Income (TTM) is -$61.7M, based on as-reported figures from SEC (XBRL) filings.

What is Palvella Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Palvella Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.28, based on as-reported figures from SEC (XBRL) filings.

What is Palvella Therapeutics, Inc. Common Stock's Net Debt?

Palvella Therapeutics, Inc. Common Stock's Net Debt is -$250.6M, based on as-reported figures from SEC (XBRL) filings.

Palvella Therapeutics, Inc. Common Stock (PVLA) Financial Statements

Palvella Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0055C3N66

XNAS · usd

152.28▼ 4.96 (-3.15%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close157.24

Day's Range151.58 – 157.93

52-Week Range52.82 – 161.38

Volume163.9K

Avg Volume181.2K

Share Statistics

Shares Outstanding

Employees29

ExchangeXNAS

Listed2024-12-16

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Palvella Therapeutics, Inc. Common Stock (PVLA)

What is Palvella Therapeutics, Inc. Common Stock's Market Cap?: Palvella Therapeutics, Inc. Common Stock's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Palvella Therapeutics, Inc. Common Stock's Enterprise Value?: Palvella Therapeutics, Inc. Common Stock's Enterprise Value is $1.9B, based on as-reported figures from SEC (XBRL) filings.
What is Palvella Therapeutics, Inc. Common Stock's Net Income (TTM)?: Palvella Therapeutics, Inc. Common Stock's Net Income (TTM) is -$61.7M, based on as-reported figures from SEC (XBRL) filings.
What is Palvella Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Palvella Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -4.28, based on as-reported figures from SEC (XBRL) filings.
What is Palvella Therapeutics, Inc. Common Stock's Net Debt?: Palvella Therapeutics, Inc. Common Stock's Net Debt is -$250.6M, based on as-reported figures from SEC (XBRL) filings.